Data source | Variable | Unit | Total data median (IQR) | Train set median (IQR) | Validation set Median (IQR) | Total data median (IQR) |
---|---|---|---|---|---|---|
Demographics | Age at admission | year | 66.0 (23.0) | 66.0 (23.0) | 65.0 (22.0) | 66.0 (23.0) |
Gender-N(%) | - | |||||
Female | 17,608 (55.75%) | 14,051 (55.61%) | 2,874 (56.87%) | 3,557 (56.3%) | ||
Male | 13,978 (44.25%) | 11,217 (44.39%) | 2,180 (43.13%) | 2,761 (43.7%) | ||
Ethnicity-N(%) | - | |||||
White | 9,706 (30.73%) | 7,779 (30.79%) | 1,528 (30.23%) | 1,927 (30.5%) | ||
African-American | 2,432 (7.7%) | 1,948 (7.71%) | 360 (7.12%) | 484 (7.66%) | ||
Hispanic-Latino | 1,059 (3.35%) | 829 (3.28%) | 181 (3.58%) | 230 (3.64%) | ||
Asian | 943 (2.99%) | 752 (2.98%) | 147 (2.91%) | 191 (3.02%) | ||
Other | 5,272 (16.69%) | 4,250 (16.82%) | 840 (16.62%) | 1,022 (16.18%) | ||
Labs and vital signs | Prothrombin time | second | 13.9 (3.6) | 13.9 (3.7) | 14.0 (3.7) | 13.9 (3.5) |
Anion gap max | mEq/L | 14.0 (5.0) | 14.0 (5.0) | 14.0 (5.0) | 14.0 (5.0) | |
Anion gap min | mEq/L | 12.0 (4.0) | 12.0 (4.0) | 12.0 (4.0) | 12.0 (4.0) | |
Bicarbonate max | mEq/L | 25.0 (4.0) | 25.0 (4.0) | 25.0 (4.0) | 25.0 (4.0) | |
Bicarbonate min | mEq/L | 23.0 (4.0) | 23.0 (4.0) | 23.0 (4.0) | 23.0 (4.0) | |
Blood urine nitrogen min | mg/dL | 14.0 (9.0) | 14.0 (9.0) | 14.0 (10.0) | 14.0 (9.0) | |
Calcium max | mg/dL | 8.6 (0.9) | 8.6 (0.9) | 8.6 (0.9) | 8.6 (0.9) | |
Calcium min | mg/dL | 8.3 (0.9) | 8.3 (0.9) | 8.3 (0.9) | 8.3 (0.9) | |
Chloride max | mEq/L | 106.0 (6.0) | 106.0 (6.0) | 106.0 (6.0) | 106.0 (6.0) | |
Creatinine max | mg/dL | 0.8 (0.3) | 0.8 (0.3) | 0.8 (0.3) | 0.8 (0.2) | |
Creatinine min | mg/dL | 0.7 (0.3) | 0.7 (0.3) | 0.7 (0.3) | 0.7 (0.3) | |
Diastolic blood pressure max | mmHg | 85.0 (23.0) | 85.0 (24.0) | 85.0 (23.0) | 85.0 (23.0) | |
eGFR | ml/min/1.73 m2 | 83.0 (34.0) | 83.0 (34.0) | 84.0 (33.0) | 83.0 (33.0) | |
Heart rate max | bpm | 99.0 (25.0) | 99.0 (25.0) | 99.0 (24.25) | 99.0 (25.0) | |
Hematocrit min | % | 31.4 (9.6) | 31.4 (9.5) | 31.4 (9.3) | 31.5 (9.4) | |
Hemoglobin min | g/dL | 10.5 (3.2) | 10.5 (3.2) | 10.5 (3.0) | 10.6 (3.2) | |
Hemoglobin max | g/dL | 11.7 (2.9) | 11.7 (2.9) | 11.7 (2.8) | 11.8 (2.9) | |
Oxygen saturation (Spo2) max | % | 100.0 (1.0) | 100.0 (1.0) | 100.0 (1.0) | 100.0 (1.0) | |
Oxygen saturation (Spo2) min | % | 93.0 (4.0) | 93.0 (4.0) | 93.0 (4.0) | 93.0 (4.0) | |
Platelets min | K/uL | 180.0 (108.0) | 180.0 (108.0) | 179.0 (108.0) | 179.0 (106.0) | |
Potassium max | mEq/L | 4.3 (0.6) | 4.3 (0.6) | 4.3 (0.6) | 4.3 (0.6) | |
Respiratory rate max | inspirations/min | 26.0 (7.0) | 26.0 (7.0) | 26.0 (7.0) | 26.0 (7.0) | |
Sodium max | mEq/L | 140.0 (5.0) | 140.0 (5.0) | 140.0 (5.0) | 140.0 (5.0) | |
Systolic blood pressure max | mmHg | 146.0 (27.0) | 146.0 (27.0) | 146.0 (28.0) | 146.0 (27.0) | |
Temperature max | Celsius | 37.22 (0.73) | 37.22 (0.73) | 37.22 (0.73) | 37.22 (0.73) | |
Urine output | ml | 200.0 (250.0) | 200.0 (250.0) | 200.0 (250.0) | 200.0 (250.0) | |
Weight max | kg | 80.0 (28.0) | 79.8 (27.9) | 79.6 (27.8) | 80.1 (27.97) | |
White blood count max | K/uL | 12.1 (7.4) | 12.1 (7.4) | 12.1 (7.4) | 12.1 (7.45) | |
White blood count min | K/uL | 9.2 (5.3) | 9.2 (5.3) | 9.2 (5.4) | 9.2 (5.3) | |
Past medical history | Obesity -N(%) | - | ||||
No(0) | 29,468 (93.29%) | 23,558 (93.23%) | 4,730 (93.59%) | 5,910 (93.54%) | ||
Yes(1) | 2,118 (6.71%) | 1,710 (6.77%) | 324 (6.41%) | 408 (6.46%) | ||
Mild liver disease -N(%) | - | |||||
No(0) | 28,979 (91.75%) | 23,184 (91.75%) | 4,624 (91.49%) | 5,795 (91.72%) | ||
Yes(1) | 2,607 (8.25%) | 2,084 (8.25%) | 430 (8.51%) | 523 (8.28%) | ||
Supplemental Oxygen -N(%) | - | |||||
No(0) | 18,110 (57.34%) | 14,437 (57.14%) | 2,895 (57.28%) | 3,673 (58.14%) | ||
Yes(1) | 13,476 (42.66%) | 1,0831 (42.86%) | 2,159 (42.72%) | 2,645 (41.86%) | ||
Sepsis -N(%) | - | |||||
No(0) | 28,767 (91.08%) | 23,000 (91.02%) | 4,596 (90.94%) | 5,767 (91.28%) | ||
Yes(1) | 2,819 (8.92%) | 2,268 (8.98%) | 458 (9.06%) | 551 (8.72%) | ||
Peripheral vascular disease-N(%) | - | |||||
No(0) | 28,351 (89.76%) | 2,2679 (89.75%) | 4,523(89.49%) | 5,672 (89.78%) | ||
Yes(1) | 3,235 (10.24%) | 2,589 (10.25%) | 531(10.51%) | 646 (10.22%) | ||
Chronic heart failure-N(%) | - | |||||
No(0) | 27,777 (87.94%) | 2,2241 (88.02%) | 4,436 (87.77%) | 5,536 (87.62%) | ||
Yes(1) | 3,809 (12.06%) | 3,027 (11.98%) | 618 (12.23%) | 782 (12.38%) | ||
Chronic kidney disease-N(%) | - | |||||
No(0) | 28,596 (90.53%) | 22,830 (90.35%) | 4,579 (90.6%) | 5,766 (91.26%) | ||
Yes(1) | 2,990 (9.47%) | 2,438 (9.65%) | 475 (9.4%) | 552 (8.74%) | ||
Cyclosporine-N(%) | - | |||||
No(0) | 31,566 (99.94%) | 25,253 (99.94%) | 5,053 (99.98%) | 6,313 (99.92%) | ||
Yes(1) | 20 (0.06%) | 15 (0.06%) | 1 (0.02%) | 5 (0.08%) | ||
Hypertension-N(%) | ||||||
No(0) | - | 16,155 (51.15%) | 12,934 (51.19%) | 2,601(51.46%) | 3,221 (50.98%) | |
Yes(1) | 15,431 (48.85%) | 12,334 (48.81%) | 2,453 (48.54%) | 3,097 (49.02%) | ||
Severe liver disease-N(%) | - | |||||
No(0) | 30,545 (96.7%) | 24,420 (96.64%) | 4,879 (96.54%) | 6,125 (96.95%) | ||
Yes(1) | 1,041 (3.3%) | 848 (3.36%) | 175 (3.46%) | 193 (3.05%) | ||
Myocardial infarction-N(%) | - | |||||
No(0) | 26,777 (84.77%) | 21,432 (84.82%) | 4,333 (85.73%) | 5,345 (84.6%) | ||
Yes(1) | 4,809 (15.23%) | 3,836 (15.18%) | 721 (14.27%) | 973 (15.4%) | ||
Tracheostomy-N(%) | - | |||||
No(0) | 31,499 (99.72%) | 25,207 (99.76%) | 5,044 (99.8%) | 6,292 (99.59%) | ||
Yes(1) | 87 (0.28%) | 61 (0.24%) | 10 (0.2%) | 26 (0.41%) | ||
Congestive heart failure-N(%) | - | |||||
No(0) | 25,137 (79.58%) | 20,139 (79.7%) | 4,042 (79.98%) | 4,998 (79.11%) | ||
Yes(1) | 6,449 (20.42%) | 5,129 (20.3%) | 1,012 (20.02%) | 1,320 (20.89%) | ||
Invasive ventilation-N(%) | - | |||||
No(0) | 22,236 (70.4%) | 17,755 (70.27%) | 3,544 (70.12%) | 4,481 (70.92%) | ||
Yes(1) | 9,350 (29.6%) | 7,513 (29.73%) | 1,510 (29.88%) | 1,837 (29.08%) | ||
Diabetes Type2-N(%) | - | |||||
No(0) | 23,896 (75.65%) | 19,140 (75.75%) | 3,893 (77.02) | 4,756 (75.28%) | ||
Yes(1) | 7,690 (24.35%) | 6,128 (24.25%) | 1,161 (22.97%) | 1,562 (24.72%) | ||
Chronic pulmonary disease-N(%) | - | |||||
No(0) | 24,177 (76.54%) | 19,321 (76.46%) | 3,861 (76.39%) | 4,856 (76.86%) | ||
Yes(1) | 7,409 (23.46%) | 5,947 (23.54%) | 1,193 (23.61%) | 1,462 (23.14%) | ||
Outcome | AKI cases – N(%) | - | 5,473 (17.32%) | 3,502 (17.32%) | 876 (17.33%) | 1,095 (17.33%) |